ALBERT DAVID
|
The Current P/E Ratio of ALBERT DAVID is 19.10.
| Share Price | ₹756.0 | Oct 23,2026 |
| Market Cap | ₹430.9 Cr | |
| Earnings-TTM | ₹22.6 Cr | TTM-Standalone Results |
| Price/Earnings | 19.10x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALBERT DAVID
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹430.9 Cr] as on Oct 23,2026
(/) Earnings [ ₹22.6 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 19.10x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay 19.10 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALBERT DAVID !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALBERT DAVID over the last five years.
Historical PE (Price/Earnings) ratio chart of ALBERT DAVID
PE Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 10.35x.
- ALBERT DAVID 's operated at median p/e ratio of 8.14x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2025 at 26.92x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2026 of 0x.
How does ALBERT DAVID 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALBERT DAVID | 22.57 | 19.10 | 430.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 34.36 | 418,204.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 81.54 | 238,497.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 81.22 | 170,481.0 |
| CIPLA LTD | 3,364.84 | 32.10 | 108,012.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 37.04 | 102,207.0 |
| MANKIND PHARMA LTD | 2,055.11 | 44.56 | 91,572.1 |
| LUPIN LTD | 5,551.01 | 15.86 | 88,028.3 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 25.04 | 112,503.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 24.32 | 90,294.0 |
| LAURUS LABS LTD | 1,090.76 | 97.78 | 106,658.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALBERT DAVID 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 15.86x |
| Max industry PE | 97.78x |
| Median industry PE | 34.36x |
| Average industry PE | 44.81x |
You may also like the below Video Courses